SCHEMBL19976961

SCHEMBL19976961

CC(C)CN/C(=N/C(=O)c1ccc(O)cc1)Nc1n[nH]c2cc(Cl)ccc12

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 9/20 0.50
MAP2K4 P45985 2/20 0.44
HDAC6 Q9UBN7 5/20 0.44
FGFR1 P11362 1/20 0.43
FGFR2 P21802 1/20 0.43
FGFR3 P22607 1/20 0.43
PIK3CD O00329 1/20 0.41
PIM1 P11309 1/20 0.41
CDK2 P24941 1/20 0.41
GSK3A P49840 1/20 0.41
AAK1 Q2M2I8 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
CHEK1 O14757 1/20 0.40
DYRK1A Q13627 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976776 0.89 GSK3B (0.48) GSK3BMAP2K4HDAC6HDAC1HDAC2
SCHEMBL19976745 0.89 GSK3B (0.45) GSK3BMAP2K4HDAC6FGFR1FGFR2
SCHEMBL19976821 0.82 HDAC6 (0.44) GSK3BMAP2K4HDAC6FGFR1FGFR2
SCHEMBL19976817 0.79 GSK3B (0.53) GSK3BMAP2K4HDAC6FGFR1FGFR2
SCHEMBL19976789 0.79 GSK3B (0.42) GSK3BHDAC6CDK2DYRK1A
SCHEMBL16752864 0.79 GSK3B (0.46) GSK3BMAP2K4HDAC6FGFR1FGFR2
SCHEMBL16752862 0.79 GSK3B (0.46) GSK3BMAP2K4HDAC6FGFR1FGFR2
SCHEMBL16769266 0.79 GSK3B (0.46) GSK3BMAP2K4HDAC6FGFR1FGFR2
SCHEMBL19976767 0.78 GSK3B (0.51) GSK3BMAP2K4HDAC6HDAC1HDAC2
SCHEMBL19976836 0.78 MAPK1 (0.41) GSK3BHDAC6CDK2HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed